Company Encyclopedia
View More
name
Principal Value ETF
PY.US
News
View More

REG - Baillie Gifford US Bank of America Corp - Holding(s) in Company

Bank of America Corporation has crossed a major threshold in its holdings in Baillie Gifford US Growth Trust PLC, as notified on December 12, 2025. The acquisition or disposal of financial instruments led to a change in voting rights, with Bank of America now holding 8.494% of total voting rights. This includes direct voting rights and rights through financial instruments, indicating a significant shift in their investment position.

London Stock Exchange·
US
BAC
+1.06%
London Stock Exchange·
US
BAC
+1.06%

Warren Buffett Says Buy This Vanguard Index Fund -- It Could Turn $400 Per Month Into $835,000 With Help From Nvidia, Apple, and Microsoft

Warren Buffett advises investing in the Vanguard S&P 500 ETF, which could turn $400 monthly into $835,000 over 30 years. The ETF provides exposure to influential companies like Nvidia, Apple, and Microsoft. Despite risks from concentration in top companies, the S&P 500 index fund has consistently generated attractive returns. Buffett believes it's the best way for average investors to gain stock market exposure, as beating the S&P 500 is challenging even for professionals.

Motley Fool·
US
MSFT
-1.02%
US
NVDA
-3.27%
US
AAPL
+0.09%
Motley Fool·
US
MSFT
-1.02%
US
NVDA
-3.27%
US
AAPL
+0.09%

REG - JTC PLC Bank of America Corp - Holding(s) in Company

JTC PLC announced that Bank of America Corporation has crossed a major shareholding threshold. As of December 5, 2025, Bank of America holds 8.516894% of voting rights in JTC PLC, including direct and indirect voting rights and financial instruments. The notification was completed on December 8, 2025.

London Stock Exchange·
US
BAC
+1.06%
London Stock Exchange·
US
BAC
+1.06%

'A Major Win for Big Tech,' Wedbush Analyst Daniel Ives Says of Trump's AI Executive Order

Wedbush analyst Daniel Ives views Trump's AI executive order as a major win for big tech companies like OpenAI, Microsoft, Alphabet, Meta, and Anthropic. The order aims to block state AI laws, promoting a unified national framework to enhance U.S. leadership in AI. Ives believes this move removes regulatory barriers, aiding U.S. competitiveness against China. The order faces criticism from states concerned about losing their ability to protect residents. Ives has a Buy rating on most of these companies, expecting significant share price appreciation.

Tip Ranks·
NA
OpenAI
0.00%
US
META
-1.30%
US
MSFT
-1.02%
Tip Ranks·
NA
OpenAI
0.00%
US
META
-1.30%
US
MSFT
-1.02%

Johnson & Johnson's Prostate Cancer Therapy Application Approved by US FDA

Johnson & Johnson announced FDA approval for its prostate cancer therapy, Akeega plus prednisone, targeting metastatic castration-sensitive prostate cancer with BRCA mutation. The approval follows a phase 3 study showing a 54% reduction in radiographic progression or death risk and a 59% delay in symptomatic progression. The safety profile aligns with other FDA-approved therapies.

fidelity·
US
JNJ
+0.75%
fidelity·
US
JNJ
+0.75%
© 2025 Longbridge｜Disclaimer